B-cell clonogenic activity of HIV-1 p17 variants is driven by PAR1-mediated EGF transactivation
Cinzia Giagulli(Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia), Arnaldo Caruso(University of Brescia)
Cited by 17
Related Papers
Steroid‐Responsive Encephalitis in Coronavirus Disease 2019
|Annals of Neurology|2020|299
Opposite Effects of HIV-1 p17 Variants on PTEN Activation and Cell Growth in B Cells
|PLoS ONE|2011|64
A persistently replicating SARS-CoV-2 variant derived from an asymptomatic individual
|Journal of Translational Medicine|2020|60
SARS-CoV-2 Infection Remodels the Phenotype and Promotes Angiogenesis of Primary Human Lung Endothelial Cells
|Microorganisms|2021|39
The Synthetic Dipeptide Pidotimod Shows a Chemokine-Like Activity through CXC Chemokine Receptor 3 (CXCR3)
|International Journal of Molecular Sciences|2019|14